Table 1.
Overall population characteristics: clinical and pathological TNM.
| Clinical Staging (cTNM) | Pathological Staging (pTNM) | ||||
|---|---|---|---|---|---|
| cT | n | % | pT | n | % |
| 1 | 2 | 0.7 | 1 | 1 | 0.3 |
| 2 | 13 | 4.6 | 2 | 8 | 2.8 |
| 3 | 87 | 30.9 | 3 | 93 | 33.0 |
| 4 | 162 | 57.4 | 4a | 147 | 52.2 |
| - | - | - | 4b | 31 | 11.0 |
| Unknown | 18 | 6.4 | Unknown | 2 | 0.7 |
| cN | n | % | pN | n | % |
| 0 | 54 | 19.2 | 0 | 16 | 5.7 |
| 1 | 208 | 73.7 | 1 | 26 | 9.2 |
| x | 8 | 2.9 | 2 | 38 | 13.5 |
| - | - | - | 3a | 92 | 32.6 |
| - | - | - | 3b | 86 | 30.5 |
| Unknown | 12 | 4.2 | Unknown | 24 | 8.5 |
| cM | n | % | pM | n | % |
| 0 | 107 | 37.9 | 0 * | 2 | 0.7 |
| 1 | 175 | 62.1 | 1 | 227 | 80.5 |
| - | - | - | Unresected metastases | 38 | 13.4 |
| - | - | - | ypM0 | 15 | 5.4 |
* Synchronous metastases diagnosed within 6 months after surgery.